- Citations, last 5 years
- 3
- Works, last 5 years
- 11
- h-index
- 17
- Scientists listed
- 2
- Grants since 2016
- 93
Grants received
2020–2025 · research · R01
Genomic and Environmental Determinants of Infant Deaths in San Diego County in 2015-2022
Christina Chambers · ID Genomics (United States) · funded by National Institutes of Health
2020–2021 · research · R44
Novel sequencing by synthesis chemistry to further reduce the cost of nucleic acid sequencing
Daniel Joseph Mazur · ID Genomics (United States) · funded by National Institutes of Health
2020–2026 · research · R01
Genomic and Environmental Determinants of Infant Deaths in San Diego County in 2015-2022
Christina Chambers · ID Genomics (United States) · funded by National Institutes of Health
2020–2021 · research · R44
A proximity ligation method to track mobile element hosts
Ivan Liachko · ID Genomics (United States) · funded by National Institutes of Health
2020–2022 · research · R44
Novel sequencing by synthesis chemistry to further reduce the cost of nucleic acid sequencing
Daniel Joseph Mazur · ID Genomics (United States) · funded by National Institutes of Health
2020–2025 · research · R01
Genomic and Environmental Determinants of Infant Deaths in San Diego County in 2015-2022
Christina Chambers · ID Genomics (United States) · funded by National Institutes of Health
2020–2022 · research · R44
Spatial and single cell analysis of tumor microenvironment by seqFISH+
Kirsten Frieda · ID Genomics (United States) · funded by National Institutes of Health
2020–2022 · research · R44
Spatial and single cell analysis of tumor microenvironment by seqFISH+
Kirsten Frieda · ID Genomics (United States) · funded by National Institutes of Health
2020–2025 · research · R01
Genomic and Environmental Determinants of Infant Deaths in San Diego County in 2015-2022
Christina Chambers · ID Genomics (United States) · funded by National Institutes of Health
2020–2021 · research · R44
A next-generation method for cytogenomics using Hi-C proximity ligation sequencing
Stephen Matthew Eacker · ID Genomics (United States) · funded by National Institutes of Health
2019–2022 · research · R44
Multiplexing methods to reduce sequencing costs
Atray Dixit · ID Genomics (United States) · funded by National Institutes of Health
2019–2023 · research · R01
Oligogenic Models of Cardiomyopathy
Matthew Neil Bainbridge · ID Genomics (United States) · funded by National Institutes of Health
2019–2024 · research · R01
Oligogenic Models of Cardiomyopathy
Matthew Neil Bainbridge · ID Genomics (United States) · funded by National Institutes of Health
2019–2023 · research · R01
Oligogenic Models of Cardiomyopathy
Matthew Neil Bainbridge · ID Genomics (United States) · funded by National Institutes of Health
2019 · research · R41
An innovative WGS platform for discovery, annotation, and interpretation of all forms of human genetic variation.
Brent Pedersen · ID Genomics (United States) · funded by National Institutes of Health
2019–2022 · research · R44
Multiplexing methods to reduce sequencing costs
Atray Dixit · ID Genomics (United States) · funded by National Institutes of Health
2019–2020 · research · R43
Multiplexing methods to reduce sequencing costs.
Atray Dixit · ID Genomics (United States) · funded by National Institutes of Health
2019 · research · R44
Novel sequencing by synthesis platform to greatly reduce the cost of nucleic acid sequencing
Mark Robin Pratt · ID Genomics (United States) · funded by National Institutes of Health
2019–2021 · research · R43
A Noninvasive, Precision Medicine Approach to Improve Breast Cancer Screening Using Cell-free RNA from Saliva.
Melanie M Mahtani · ID Genomics (United States) · funded by National Institutes of Health
2019–2023 · research · R01
Oligogenic Models of Cardiomyopathy
Matthew Neil Bainbridge · ID Genomics (United States) · funded by National Institutes of Health
2019–2020 · research · R44
Novel sequencing by synthesis platform to greatly reduce the cost of nucleic acid sequencing
Mark Robin Pratt · ID Genomics (United States) · funded by National Institutes of Health
2018–2020 · research · R43
Spatial Genomics for in situ single cell expression analysis in the brain
Kirsten Frieda · ID Genomics (United States) · funded by National Institutes of Health
2018–2025 · research · R42
Robust Predictor of Colon Cancer Risk
Harry Ostrer · ID Genomics (United States) · funded by National Institutes of Health
2018–2022 · research · R44
Spatial Genomics for in situ single cell expression analysis in the brain
Kirsten Frieda · ID Genomics (United States) · funded by National Institutes of Health
2018–2019 · research · R41
Reprogrammed T Cells to prevent graft versus host disease
Joseph J Bellucci · ID Genomics (United States) · funded by National Institutes of Health
2018–2019 · research · R43
Combining Next-Generation Sequencing and Advanced Algorithms to Elucidate Tumor Heterogeneity
Patrice M Milos · ID Genomics (United States) · funded by National Institutes of Health
2018–2019 · research · R43
Spatial Genomics for in situ single cell expression analysis in the brain
Kirsten Frieda · ID Genomics (United States) · funded by National Institutes of Health
2018–2020 · research · R43
A Noninvasive Platform to Assess Maternal Risk for Perinatal Complications in the First Trimester
David Randall Armant · ID Genomics (United States) · funded by National Institutes of Health
2018–2022 · research · R44
Spatial Genomics for in situ single cell expression analysis in the brain
Kirsten Frieda · ID Genomics (United States) · funded by National Institutes of Health
2018–2020 · research · R43
A Noninvasive Prenatal Testing Platform for Aneuploidy at Five Weeks of Gestation
David Randall Armant · ID Genomics (United States) · funded by National Institutes of Health
2018–2019 · research · R41
Automated preparation of single-cells and nuclei from solid tissues
Stevan B Jovanovich · ID Genomics (United States) · funded by National Institutes of Health
2018–2019 · research · R43
Spatial Genomics for in situ single cell expression analysis in the brain
Kirsten Frieda · ID Genomics (United States) · funded by National Institutes of Health
2018–2024 · research · R42
Robust Predictor of Colon Cancer Risk
Harry Ostrer · ID Genomics (United States) · funded by National Institutes of Health
2018–2020 · research · R41
An innovative WGS platform for discovery, annotation, and interpretation of all forms of human genetic variation.
Brent Pedersen · ID Genomics (United States) · funded by National Institutes of Health
2018–2020 · research · R41
Robust Predictor of Colon Cancer Risk
Harry Ostrer · ID Genomics (United States) · funded by National Institutes of Health
2017–2019 · research · R41
Robust Predictor of Breast Cancer Risk
Harry Ostrer · ID Genomics (United States) · funded by National Institutes of Health
2017–2019 · research · R43
Cost effective high-quality genome assembly for non-model organisms
Ryan Waldo Taylor · ID Genomics (United States) · funded by National Institutes of Health
2017–2022 · research · R42
Robust Predictor of Breast Cancer Risk
Harry Ostrer · ID Genomics (United States) · funded by National Institutes of Health
2017–2021 · research · R44
A Platform for Safe, Noninvasive Prenatal Genetic Testing at Five Weeks of Pregnancy
David Randall Armant · ID Genomics (United States) · funded by National Institutes of Health
2017–2022 · research · R44
A Platform for Safe, Noninvasive Prenatal Genetic Testing at Five Weeks of Pregnancy
David Randall Armant · ID Genomics (United States) · funded by National Institutes of Health